$62.31

0.37 (0.60%)

11/20/2009 4:00 PM

Johnson & Johnson (JNJ)

CAPS Rating:

Engaged in the research and development, manufacture and sale of a range of products in the health care field in many countries of the world.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating JNJ

Add Stock to Watchlist

What the Community Thinks

Total Members

12060 Outperforms

416 Underperforms

All-Stars

2997 Outperforms

59 Underperforms

Wall Street

30 Outperforms

1 Underperforms

Members bullish on JNJ are also bullish on:

Members bearish on JNJ are also bearish on:

Ticker Tags

Blue Chip (113), Mega Cap (115), Pharmaceuticals (150), Growth (1883), New Brunswick (1), New Jersey (6), Top Brands 2006 (59), Diversified Conglomerate (16), Dow (29), Income (1472), Big Pharma (10), Dividend (191), S&P 500 (500), Buffett Stock (45), Behemoth (31), Top Brands 2005 (58), Healthcare (733), Defensive (1498), Medical Device (38), Multinational Company (15)
Suggest a tag

Johnson & Johnson At A Glance

Current Price:	$62.31
Last Trade Time:	11/20/2009 4:00 PM
Open:	$61.82
Previous Close:	$61.94
Daily Range:	$61.72 - $62.62
52-Week Range:	$46.25 - $62.74
Volume:	16,299,234
Market Cap:	$171.92B
P/E Ratio:	13.51
Compare Our Special Broker Offers!

Stock Trends

JNJ VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for JNJ

This Week's 'Barron's' Roundup
11/22/2009 11:16:41 AM -
$ 10 for the Money
11/21/2009 11:23:00 AM -
Dollar Could Steer Stocks in Coming Week
11/21/2009 9:01:23 AM -
FDA OKs Abilify for autism-linked irritability
11/20/2009 7:27:58 PM -

More Headlines...

Top Bull Pitch

Recs

23 Johnson & Johnson (JNJ)

Avatar poppycock2 (62.03) Submitted: 8/24/09 3:37 PM

Been around many years, solid management, plenty of cash to buy Biotech companies with promising drugs, sell things people actually need and use, pays a solid dividend which over time will help you build wealth

Replies: 5 | Reply | Permalink

Top Bear Pitch

Recs

1 Johnson & Johnson (JNJ)

Avatar Alleymae (< 20) Submitted: 6/19/08 11:57 AM

Believe that republicians will regain control of the white house and congress, making the economy even tighter, which should reduce the sizes of households, JNJ services mostly households, causing a drop.

Replies: 3 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 1980 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (JNJ) spotpetes (68.83) Submitted: 11/18/09 3:50 PM : Start Price: $62.45 JNJ Score: -1.46 BORING!! when things get better jnj will go down, too conservitive in this market. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) scluffman (69.86) Submitted: 11/18/09 12:38 AM : Start Price: $62.07 JNJ Score: 2.03 I cannot help but feel the broader market indexes are due for a pullback. Too fast a climb over the last 6 months plus has anyone noticed how volume is drying up at an alarming rate? So why am I bullish on JNJ? Because if I'm right about the overall markets, then you should see a flight to safety into solid blue-chips with good dividends and JNJ fits the bill to a "T". So while I'm not at all confident that JNJ will actually gain over the next few months, I do believe it will outperform the S&P 500. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) TheChartist13 (58.15) Submitted: 11/15/09 5:32 PM : Start Price: $61.45 JNJ Score: 2.26 A solid defensive company that has excellent product development and growth. I like this defensive name to 70 if it can get there but i would take some profit at 65. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (JNJ) Aneirin (36.84) Submitted: 11/13/09 5:40 PM : Start Price: $61.45 JNJ Score: 2.26 Good dividend and generally an industry leader. This company also has high RO and ROE, and a low P/E. A good pick over several years. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 4 (JNJ) Jim2B (64.61) Submitted: 11/06/09 3:55 PM : Start Price: $60.01 JNJ Score: 17.71 Overall based upon accelerating (home & business) foreclosures, financial weakness in the banking sector, tremendous tax increases on the horizon (suppressing the economy), and a federal spending policy that can only result in double digit inflation, I expect the economy (& stock prices) to decline over the remainder of 2009 and through 2010 at the least. So the question is not whether JNJ goes up or down but by how it does in relation to the S&P500. JNJ's sterling financial strength and proven management team provides it a great deal of protection against possible declines in the economy. In fact any company with strong financials should perform better than the market average in a down economy. Now with the prospect of a government run health care bill raising punitive taxes upon any company in that sector, expect the price to remain depressed until everything sorts out. Still given the fact that JNJ has a lot of non-health care related business over which it can distribute those taxes, it should not be as adversely affected as say PFE or MRK. So I expect the stock price to remain depressed over the short term (giving you time to buy the stock) with a nice bump if Congress fails to pass something before the end of the year. In the mid-term, conservative management, good management, and good financial strength will preserve stock price values better than other S&P500 companies. In the long-term expect JNJ stock prices to rise when the economy improves in line with other companies. Overall, I'd say that JNJ is a safe bet with reasonable upside and limited downside. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 1980 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 31 of 31

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackJimCramer	36.31	10/15/09		3W	$60.94	+2.25%	-0.26%	-2.50
	TrackStandpoint	90.98	04/29/09		NS	$50.09	+24.39%	+25.63%	-1.24
	TrackWachovia	< 20	04/20/09		NS	$52.28	+19.17%	+29.26%	-10.09
	TrackUBS	88.39	03/20/09		NS	$50.24	+24.03%	+40.39%	-16.36
	TrackFortune2009	49.62	12/11/08		1Y	$56.81	+9.69%	+28.70%	-19.01
	TrackBobOlstein	48.20	06/18/08		5Y	$62.74	-0.69%	-15.65%	+14.96
	TrackGaryBSmith	34.74	02/15/08		3W	$59.64	+4.48%	-15.61%	+20.09
	TrackStanfordRes	78.48	01/23/08		NS	$60.75	+2.57%	-10.90%	+13.47
	TrackHeebner	38.83	12/31/07		NS	$63.24	-1.47%	-22.00%	+20.53
	TrackEdwardOwens	98.46	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackHAndW	24.72	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackRichAster	91.02	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackBRogers	96.87	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackRichPzena	< 20	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackVanDenBerg	69.91	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackEveillard	88.00	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackJohnRogers	< 20	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackBuffett	74.48	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackDodgeCox	88.49	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackBrandes	< 20	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackHillman	95.59	09/30/07		NS	$61.91	+0.64%	-24.86%	+25.50
	TrackMichaelBrus	90.02	08/08/07		1Y	$58.49	+6.53%	-22.75%	+29.28
	TrackPatDorsey	71.52	04/27/07		3Y	$59.68	+4.41%	-22.63%	+27.04
	TrackDeutscheSec	87.23	04/18/07		NS	$59.85	+4.12%	-21.49%	+25.60
	TrackMichaelSivy	91.53	03/20/07		1Y	$55.83	+11.61%	-17.93%	+29.54
	TrackCharlesPayn	50.19	02/24/07		3M	$59.66	+4.44%	-20.06%	+24.50
	TrackKiplinger	56.00	01/03/07		1Y	$61.40	+1.49%	-17.84%	+19.33
	TrackScottBleier	59.56	10/28/06		3M	$63.40	-1.72%	-15.80%	+14.08
	TrackWayneRogers	< 20	10/13/06		3M	$60.06	+3.75%	-14.96%	+18.70
	TrackHilliard	46.39	10/05/06		NS	$60.38	+3.20%	-13.89%	+17.09
	TrackBofASec	91.37	09/05/06		NS	$59.73	+4.32%	-11.29%	+15.61

Results 1 - 31 of 31

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.